Doylestown, PA – According to filings with the U.S. Securities and Exchange Commission, NewIV Medical is raising $5,881,482.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jerry Ruddle played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About NewIV Medical

NewIV is a management, development and commercialization team with deep experience in the field of medical technology.   The management team, Board of Directors and business partners of NewIV represent years of success in finance, development, manufacturing, commercialization, distribution, sales and support in the medical device and diagnostic markets, with specialized expertise in the infusion pump and home infusion delivery services markets. Our clinical partnerships enable a care provider and patient care focus for the products we deliver.

To learn more about NewIV Medical, visit http://newivmed.com/

Contact:
Jerry Ruddle, Chief Executive Officer
267-895-1747
https://www.linkedin.com/in/jerryruddle/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved